BANK OF HAWAII

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 315080 HONOLULU, HI

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$593,610

-$197,573 QoQ

Shares Held

952

-7.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#760

of 1,320 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANK OF HAWAII holds $4,409,468 across 4 Biotechnology names. REGN ranks #3 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	29,276	$2,386,286
2	DNTH	Dianthus Therapeutics, Inc. /DE/	10,180	$992,346
3	REGN	Regeneron Pharmaceuticals, Inc. This page	952	$593,610
4	ABVX	Abivax S.A.	3,281	$437,226

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$593,610	952	-7.0%	Shares	Defined	2026-08-14
2026-03-31	$791,183	1,024	-2.4%	Shares	Defined	2026-05-15
2025-12-31	$809,691	1,049	+2.5%	Shares	Defined	2026-03-03
2025-09-30	$575,202	1,023	+36.9%	Shares	Defined	2025-11-14
2025-06-30	$392,175	747	+106.9%	Shares	Defined	2025-08-14
2020-09-30	$202,080	361	-29.4%	Shares	Defined	2020-11-13
2020-06-30	$318,685	511	-57.0%	Shares	Defined	2020-08-14
2020-03-31	$579,600	1,187	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.